To hear about similar clinical trials, please enter your email below
Trial Title:
Association of Apical Periodontitis With Systemic Level of Inflammatory Markers : A Longitudinal Intervention Study
NCT ID:
NCT05814965
Condition:
Diabetes Mellitus, Type 2
Apical Periodontitis
Conditions: Official terms:
Periodontitis
Periapical Periodontitis
Diabetes Mellitus
Diabetes Mellitus, Type 2
Conditions: Keywords:
Apical Periodontitis
Diabetes mellitus
High sensitivity C-reactive protein
Tumor necrosis factor-alpha
Interleukin
Glycated hemoglobin
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Non-Randomized
Intervention model:
Parallel Assignment
Intervention model description:
280 patients 140 in DM (70 each with AP and 70 without AP) and 140 Systemically healthy
(70 each with AP and 70 without AP)will be enrolled and compared for systemic markers
.Subjects with AP will be provided Endodontics treatment and levels of markers will be
assessed one year after Endodontics treatment. markers.
Primary purpose:
Treatment
Masking:
Triple (Care Provider, Investigator, Outcomes Assessor)
Intervention:
Intervention type:
Procedure
Intervention name:
endodontic treatment in the form of root canal treatment
Description:
Patients will receive endodontic treatment, and inflammatory markers will be assessed
Arm group label:
Diabetic patients with Apical periodontitis
Other name:
RCT
Intervention type:
Procedure
Intervention name:
endodontic treatment
Description:
Patients will receive endodontic treatment in the form of root canal treatment, and
inflammatory markers will be assessed along with metabolic markers assessment
Arm group label:
Healthy patients with Apical periodontitis
Intervention type:
Diagnostic Test
Intervention name:
assessment of inflammatory marker
Description:
assessment of inflammatory markers
Arm group label:
Healthy participants without Apical periodontitis
Intervention type:
Diagnostic Test
Intervention name:
inflammatory markers will be assessed along with metabolic markers assessment
Description:
inflammatory markers will be assessed along with metabolic markers assessment
Arm group label:
Diabetic patients with out Apical periodontitis
Summary:
While cross-sectional studies have reported a significant association between diabetes
and Apical Periodontics, prospective studies are scarce. This will be the first
prospective interventional study to explore the cause-and-effect relation between AP and
diabetes by assessment of levels of inflammatory markers in a longitudinal setting.
Periapical healing in diabetics and nondiabetics will be compared after root canal
treatment to evaluate the role of various physical and metabolic attributes on endodontic
outcomes.
Detailed description:
This prospective longitudinal interventional study will be conducted on patients with
radiographic evidence of AP in at least one teeth. Total of 280 patients will be selected
from the pool of the patients referred to the Outpatient Department of Conservative
Dentistry and Endodontics, Post Graduate Institute of Dental Sciences, Rohtak. They will
be equally divided into two broad groups either without any systemic disease (140
patients) or with type 2 DM.(140 Patients with DM). Each group further divided into 70
patients with AP and 70 control in a systemically healthy group (selected to match
participants in age, sex and BMI). Similarly,70 patients with AP and 70 control for
participants with type 2 DM will be selected to additionally match with glycaemic
control, drugs, and dietary measures apart from other physical attributes.
Analysis of systemic inflammatory markers IL-1b, IL-6, TNF- α and hsCRP will be done at
baseline in both healthy and diabetic participants. Root canal treatment will be done in
all the participants with AP and assessment of periapical healing and change in
inflammatory markers will be done at 3, 6, and 12-month follow-up.
Sample size: Sample size was estimated based on the difference in hsCRP level in patients
with AP and healthy control. Effect size of 0.52 was calculated based on the mean
difference and pooled SD of 0.91 and 1.75 respectively. Sample size of 58 per group was
obtained at 80% power and 0.05 alpha level. Anticipating 20% dropout, total 70 patients
per group (in 4 groups total 280 patients)will be recruited.
Root Canal treatment Access opening will be done after rubber dam isolation and
administration of local anesthesia.
debridement of the pulp chamber will be done and all canal orifices will be identified.
Negotiation of canals will be done. Working length will be determined using root ZX apex
locator and will be verified radiographically. Root canal treatment will be performed
with protaper rotary instrument using standard protocol. Coronal 2/3rd pre-enlargement
will be performed with S1 and S2 files and apical third will be prepared with S1 followed
by S2 and suitable finishing files depending on the size of apical binding file.
Irrigation will be carried out using 5 mL of a 5% NaOCl solution between files. After
preparation, the root canals will be irrigated with 5 mL 17% EDTA for 3 minutes to remove
smear layer, followed by 5 mL 5% NaOCl. The final irrigation will be done with 5 mL
distilled water. Intracanal dressing of Calcium hydroxide will be applied for 7 days and
obturation of canal will be performed after 7 days on 2nd visit. The root canals will be
dried using paper points and filled with laterally condensed gutta-percha (Dentsply
Maillefer) and AH plus resin-after manipulation following manufacturers' instructions.
Gutta- percha will be cut with a heated instrument and vertically condensed right at the
orifice opening of the canals. Final composite resin restoration will be performed
following manufacturer instruction. All the posterior teeth will be metal/ceramic crown
after the completion of root canal treatment.
Follow up Follow-up and clinical and radiographic examinations will be carried out after
every three months for one year. Glycaemic control in diabetes patients will also be
evaluated by HbA1c values at each follow-up interval.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Patients 30-55 year age group with minimum 20 natural teeth, with pulp necrosis
confirmed by cold test and electric pulp test and radiographic evidence of
periapical radiolucency with PAI score of ≥3 (24) or more in at least one mature
tooth.
- control in the systemically healthy group will be selected to match participants in
terms of age, sex, and BMI.
- control for participants with type 2 DM will be selected to additionally match with
glycaemic control, drugs and dietary measures apart from other physical attributes.
Exclusion Criteria:
- Patients with clinical diagnosis of moderate to severe periodontitis (≥6 sites with
probing depth ≥5 mm at separate teeth, with attachment loss and radiographic
alveolar bone loss), Patients with immunosuppression, pregnancy, conditions
requiring prophylactic antibiotics prior to dental treatment, bleeding disorders,
medical conditions that may affect study participation (e.g., unstable
cardiovascular disease) and chronic inflammatory conditions like rheumatoid
Gender:
All
Minimum age:
30 Years
Maximum age:
55 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
PGIDS
Address:
City:
Rohtak
Zip:
124001
Country:
India
Status:
Recruiting
Contact:
Last name:
Dr. Sanjay Tewari, MDS
Phone:
01262283876
Email:
principalpgids@yahoo.in
Start date:
April 5, 2023
Completion date:
December 2025
Lead sponsor:
Agency:
Postgraduate Institute of Dental Sciences Rohtak
Agency class:
Other
Source:
Postgraduate Institute of Dental Sciences Rohtak
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05814965